Litcius/Paper detail

Therapy for Stage IV Non–Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2025.1

Dwight H. Owen, Balázs Halmos, Sonam Puri, Angel Qin, Nofisat Ismaila, Fawzi Abu Rous, Krishna Alluri, Janet Freeman‐Daily, Narinder K. Malhotra, Kristen A. Marrone, Lyudmila Bazhenova

2025Journal of Clinical Oncology7 citationsDOI

Abstract

Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the ASCO Guidelines Methodology Manual . ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines . Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See appendix for disclaimers and other important information ( Appendix 1 and Appendix 2 ). Updates are published regularly and can be found at https://ascopubs.org/nsclc-non-da-living-guideline .

Topics & Concepts

MedicineGuidelineClinical PracticeFamily medicineLung cancerStage (stratigraphy)Clinical OncologyMedical physicsCancerPathologyInternal medicineBiologyPaleontologyLung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentCancer Immunotherapy and Biomarkers
Therapy for Stage IV Non–Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2025.1 | Litcius